A thought-leadership discussion about the advantages and limitations of genetic and genomic testing and how the results can inform cancer treatment options. AllMed Vice President and Medical Director, Kathryn Kolonic, DO, MPH, CPHQ will lead a discussion with expert board-certified specialists.
- Dr Catherine Ziats, Clinical Genetics and Genomics at Shodair Children’s Hospital
- Dr Jamie Koprivnikar, Hematology, Medical Oncology and Internal Medicine at John Theurer Cancer Center at Hackensack University Medical Center
In this webinar, the panel will review the similarities and differences between genetic and genomic testing. You will learn about the types of cancer and new treatment options that genetic and genomic tests can inform, as well as the associated survival statistics. The panel will also discuss value-based care and cost containment models for determining the cost effectiveness of genetic or genomic testing relative to having a meaningful impact on patient outcomes.